Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study

go back to reference Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M, Mokdad AH, Nixon MR, Reiner RC, Sartorius B, Smith M, Topor-Madry R, Werdecker A, Vos T, Feigin VL, Murray CJL (2019) Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M, Mokdad AH, Nixon MR, Reiner RC, Sartorius B, Smith M, Topor-Madry R, Werdecker A, Vos T, Feigin VL, Murray CJL (2019) Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol

go back to reference Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225–238PubMedCrossRef Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225–238PubMedCrossRef

go back to reference Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169–180PubMedPubMedCentralCrossRef Reich DS, Lucchinetti CF, Calabresi PA (2018) Multiple sclerosis. N Engl J Med 378(2):169–180PubMedPubMedCentralCrossRef

go back to reference Lassmann H (2018) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116PubMedCrossRef Lassmann H (2018) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116PubMedCrossRef

go back to reference Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14(3):271–278PubMedCrossRef Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14(3):271–278PubMedCrossRef

go back to reference Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(5):1175–1189PubMedPubMedCentralCrossRef Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(5):1175–1189PubMedPubMedCentralCrossRef

go back to reference Petzold A. (2018) Neurodegeneration and multiple sclerosis. In: NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers.; 379–400 Petzold A. (2018) Neurodegeneration and multiple sclerosis. In: NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers.; 379–400

go back to reference Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BMJ, Petzold A, Green AJ (2016) Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 263(7):1323–1331PubMedPubMedCentralCrossRef Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BMJ, Petzold A, Green AJ (2016) Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 263(7):1323–1331PubMedPubMedCentralCrossRef

go back to reference Costello F, Burton J (2018) Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis? Eye Brain 10:47–63PubMedPubMedCentralCrossRef Costello F, Burton J (2018) Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis? Eye Brain 10:47–63PubMedPubMedCentralCrossRef

go back to reference Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:1–17CrossRef Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:1–17CrossRef

go back to reference Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedPubMedCentralCrossRef Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedPubMedCentralCrossRef

go back to reference Petzold A, Balcer L, Calabresi PA et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797–812PubMedCrossRef Petzold A, Balcer L, Calabresi PA et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797–812PubMedCrossRef

go back to reference Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932PubMedCrossRef Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932PubMedCrossRef

go back to reference Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 113(2):324–332PubMedCrossRef Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 113(2):324–332PubMedCrossRef

go back to reference Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574–584PubMedCrossRef Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574–584PubMedCrossRef

go back to reference Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 69(16):1603–1609PubMedCrossRef Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 69(16):1603–1609PubMedCrossRef

go back to reference Saidha S, Al-Louzi O, Ratchford JN et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801–813PubMedPubMedCentralCrossRef Saidha S, Al-Louzi O, Ratchford JN et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801–813PubMedPubMedCentralCrossRef

go back to reference Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972PubMedPubMedCentralCrossRef Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972PubMedPubMedCentralCrossRef

go back to reference Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 135(6):1786–1793PubMedPubMedCentralCrossRef Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 135(6):1786–1793PubMedPubMedCentralCrossRef

go back to reference Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 68(18):1488–1494PubMedCrossRef Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 68(18):1488–1494PubMedCrossRef

go back to reference Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA (2013) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 80(1):47–54PubMedPubMedCentralCrossRef Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA (2013) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 80(1):47–54PubMedPubMedCentralCrossRef

go back to reference Pisa M, Guerrieri S, Di Maggio G et al (2017) No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. Neurology. 89(24):2469–2475PubMedCrossRef Pisa M, Guerrieri S, Di Maggio G et al (2017) No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. Neurology. 89(24):2469–2475PubMedCrossRef

go back to reference Talman LS, Bisker ER, Sackel DJ, Long da Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral Talman LS, Bisker ER, Sackel DJ, Long da Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral

go back to reference Garcia-Martin E, Pueyo V, Almarcegui C, Martin J, Ara JR, Sancho E, Pablo LE, Dolz I, Fernandez J (2011) Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 95(11):1577–1582PubMedCrossRef Garcia-Martin E, Pueyo V, Almarcegui C, Martin J, Ara JR, Sancho E, Pablo LE, Dolz I, Fernandez J (2011) Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 95(11):1577–1582PubMedCrossRef

go back to reference Gabilondo I, Sanchez-Dalmau B, Berenguer J et al (2013) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRef Gabilondo I, Sanchez-Dalmau B, Berenguer J et al (2013) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRef

go back to reference Geurts JJG, Bö L, Pouwels PJW et al (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26(3):572–577PubMed Geurts JJG, Bö L, Pouwels PJW et al (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26(3):572–577PubMed

go back to reference Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJM, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254(9):1212–1220PubMedCrossRef Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJM, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254(9):1212–1220PubMedCrossRef

go back to reference Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 133(6):1591–1601PubMedPubMedCentralCrossRef Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 133(6):1591–1601PubMedPubMedCentralCrossRef

go back to reference Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef

go back to reference Pietroboni AM, Dell’Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, de Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31–38CrossRef Pietroboni AM, Dell’Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, de Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31–38CrossRef

go back to reference Pietroboni AM, Schiano Di Cola F, Scarioni M et al (2017) CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Mult Scler 23(8):1085–1091PubMedCrossRef Pietroboni AM, Schiano Di Cola F, Scarioni M et al (2017) CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Mult Scler 23(8):1085–1091PubMedCrossRef

go back to reference Pietroboni AM, Caprioli M, Carandini T, et al. (2018) CSF β-amyloid predicts prognosis in patients with multiple sclerosis. Mult Scler J 135245851879170 Pietroboni AM, Caprioli M, Carandini T, et al. (2018) CSF β-amyloid predicts prognosis in patients with multiple sclerosis. Mult Scler J 135245851879170

go back to reference Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, de Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G (2019) Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. Eur J Nucl Med Mol Imaging 46(2):280–287PubMedCrossRef Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, de Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G (2019) Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. Eur J Nucl Med Mol Imaging 46(2):280–287PubMedCrossRef

go back to reference Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol

go back to reference Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH, Klistorner A (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317PubMedCrossRef Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH, Klistorner A (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317PubMedCrossRef

go back to reference Pietroboni AM, Schiano di Cola F, Colombi A et al (2020) CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis. Mult Scler Relat Disord 37:101462. https://doi.org/10.1016/j.msard.2019.101462PubMedCrossRef Pietroboni AM, Schiano di Cola F, Colombi A et al (2020) CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis. Mult Scler Relat Disord 37:101462. https://​doi.​org/​10.​1016/​j.​msard.​2019.​101462PubMedCrossRef

go back to reference Pietroboni AM, Colombi A, Carandini T et al (2020) Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis. Mult Scler Relat Disord 39:101899. https://doi.org/10.1016/j.msard.2019.101899CrossRef Pietroboni AM, Colombi A, Carandini T et al (2020) Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis. Mult Scler Relat Disord 39:101899. https://​doi.​org/​10.​1016/​j.​msard.​2019.​101899CrossRef